Table 2.
Cardiometabolic risk factor levels of 269 Chinese participants with hyperlipidemia according to gender 1,2.
| Cardiometabolic Risk Factors | All (n = 269) |
Female (n = 202) |
Male (n = 67) |
p Values |
|---|---|---|---|---|
| Lipid and lipoprotein profiles | ||||
| Triglyceride, mmol/L | 2.0 ± 1.4 | 1.9 ± 1.3 | 2.5 ± 1.7 | 0.020 |
| TC, mmol/L | 6.2 ± 1.0 | 6.3 ± 1.0 | 5.8 ± 1.0 | <0.001 |
| LDL-C, mmol/L | 4.2 ± 1.0 | 4.3 ± 1.0 | 3.9 ± 1.0 | 0.004 |
| HDL-C, mmol/L | 1.5 ± 0.4 | 1.6 ± 0.4 | 1.3 ± 0.4 | <0.001 |
| TC:HDL-C ratio | 4.4 ± 1.2 | 4.2 ± 1.2 | 4.9 ± 1.2 | <0.001 |
| LDL-C:HDL-C ratio | 3.0 ± 0.9 | 2.9 ± 0.9 | 3.2 ± 0.8 | 0.005 |
| ApoA1, g/L | 1.5 ± 0.3 | 1.5 ± 0.3 | 1.3 ± 0.2 | <0.001 |
| ApoB, g/L | 1.3 ± 0.3 | 1.3 ± 0.3 | 1.3 ± 0.2 | 0.176 |
| ApoA1:ApoB ratio | 1.2 ± 0.4 | 1.2 ± 0.4 | 1.1 ± 0.3 | 0.004 |
| Glucose homeostasis biomarkers | ||||
| Glucose, mmol/L | 5.4 ± 1.1 | 5.4 ± 1.1 | 5.4 ± 1.1 | 0.938 |
| HbA1c, % | 5.8 ± 0.7 | 5.8 ± 0.7 | 5.7 ± 0.7 | 0.765 |
| Blood pressure | ||||
| Systolic blood pressure, mm Hg | 115.1 ± 16.7 | 113.2 ± 16.6 | 120.6 ± 16.1 | 0.002 |
| Diastolic blood pressure, mm Hg | 73.2 ± 10.2 | 71.6 ± 9.8 | 78.0 ± 9.9 | <0.001 |
1 Data are presented as mean ± SD. Apo, apolipoprotein; HbA1c, glycated hemoglobin A1c; HDL-c, high density lipoprotein; LDL-c, low density lipoprotein cholesterol; TC, total cholesterol. 2 Differences in cardiometabolic risk factor levels between female and male participants were compared using 2-sample t test.